Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kevin R. Carlson"'
Autor:
Robert Parks, Kelly E. Seaton, Barton F. Haynes, Jim Tartaglia, Jeffrey Tomalka, Muhammad Bilal Latif, Georgia D. Tomaras, Slim Fourati, Ana María González, Adam Pelletier, Nelson L. Michael, Richard A. Koup, Rafick Pierre Sekaly, Peter Wilkinson, Genoveffa Franchini, Merlin L. Robb, Norman L. Letvin, Kathryn Furr, Sampa Santra, Michelle A. Lifton, Nicole L. Yates, Ashish Sharma, Kevin R. Carlson
Publikováno v:
Nature Immunology. 22:1294-1305
Development of effective human immunodeficiency virus 1 (HIV-1) vaccines requires synergy between innate and adaptive immune cells. Here we show that induction of the transcription factor CREB1 and its target genes by the recombinant canarypox vector
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5894e65d5dda882b45064379bbab429a
https://doi.org/10.1038/s41590-021-01026-9
https://doi.org/10.1038/s41590-021-01026-9
Autor:
Angela Carville, Kevin R. Carlson, Birgit Korioth-Schmitz, Norman L. Letvin, Harikrishnan Balachandran, Barton F. Haynes, Mark Cayabyab, Yue Sun, Adam P. Buzby, William R. Jacobs, Ayako Miura
Publikováno v:
Journal of Virology. 83:5505-5513
While mycobacteria have been proposed as vaccine vectors because of their persistence and safety, little has been done systematically to optimize their immunogenicity in nonhuman primates. We successfully generated recombinant Mycobacterium bovis BCG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3391433898129f6712dbd2a6f61a259c
https://doi.org/10.1128/jvi.02544-08
https://doi.org/10.1128/jvi.02544-08
Autor:
Gary J. Nabel, John R. Mascola, Ryon H. Clarke, Adam P. Buzby, Pamela A. Kozlowski, Vanessa M. Hirsch, Jenny G. Parvani, Birgit Korioth-Schmitz, Vi Dang, Norman L. Letvin, Kevin R. Carlson, Liat Bar, Dilani Dombagoda, Srini S. Rao
Publikováno v:
Journal of virology. 81(22)
Defining the immune correlates of the protection against human immunodeficiency virus type 1 (HIV-1) acquisition in individuals who are exposed to HIV-1 but do not become infected may provide important direction for the creation of an HIV-1 vaccine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0602f3af981f6cd81e8e4387020e4a
https://pubmed.ncbi.nlm.nih.gov/17686853
https://pubmed.ncbi.nlm.nih.gov/17686853
Autor:
Kevin R. Carlson, Bernhard Dietzschold, David C. Montefiori, Matthias J. Schnell, James P. McGettigan, Roger J. Pomerantz, Philip M. McKenna, Amy B. Papaneri, Martin Koser, Peter Silvera, Norman L. Letvin
Publikováno v:
The Journal of infectious diseases. 195(7)
We analyzed the safety and immunogenicity of attenuated rabies virus vectors expressing simian-human immunodeficiency virus (SHIV)-1(89.6P) Env or simian immunodeficiency virus (SIV)(mac239) Gag in rhesus macaques. Four test macaques were immunized w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea534d4c08715ffbdd5dab219cebb51d
https://pubmed.ncbi.nlm.nih.gov/17330788
https://pubmed.ncbi.nlm.nih.gov/17330788
Autor:
Zhi Yong Yang, Mark Muldoon, Linh Mach, Harikrishnan Balachandran, Adam P. Buzby, Bette T. Korber, Krisha McKee, Kevin R. Carlson, John R. Mascola, Wing Pui Kong, Gary J. Nabel, Sydeaka Watson, Srinivas S. Rao, Norman L. Letvin, Sampa Santra
Publikováno v:
Virology. (2):121-127
To create an HIV-1 vaccine that generates sufficient breadth of immune recognition to protect against the genetically diverse forms of the circulating virus, we have been exploring vaccines based on consensus and mosaic protein designs. Increasing th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26276c87d56d32229ddc7344847d4e49